• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 0.00% 9.0¢

NEUROTECH INTERNATIONAL LIMITED - News & Media

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused on the development and commercialization of neurological solutions focused predominately on pediatric neurological disorders. The Company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its NTI/Dolce cannabis strains. It is also commercializing Mente, a home therapy to increase engagement and improve relaxation in autistic children with elevated delta-band brain activity. Its product, Mente Autism, assists with the management of children with autism spectrum disorder (ASD). Its development program NTI164 completed a Phase I/II clinical trial to treat patients with autism spectrum disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to helo-relax the minds of children with ASD. More

(20min delay)
Last
9.0¢
Change
0.000(0.00%)
Mkt cap ! $82.56M
Open High Low Value Volume
8.9¢ 9.0¢ 8.7¢ $126.8K 1.439M

Buyers (Bids)

No. Vol. Price($)
1 18916 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 236884 7
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
8.9¢
  Change
0.000 ( 1.11 %)
Open High Low Volume
8.8¢ 9.0¢ 8.7¢ 178950
Last updated 15.49pm 26/04/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.